{
    "root": "e4c5fe1d-4ca1-9fdc-68ed-a5bf3b29b85a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ONDANSETRON",
    "value": "20250307",
    "ingredients": [
        {
            "name": "ONDANSETRON HYDROCHLORIDE",
            "code": "NMH84OZK2B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7774"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "Hypromellose 2910 (5 Mpa.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "lactose monohydrate",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "magnesium stearate",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "Polyethylene Glycol, Unspecified",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "titanium dioxide",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "Hypromellose 2910 (6 Mpa.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        }
    ],
    "indications": {
        "text": "ondansetron tablets indicated prevention nausea vomiting associated : highly emetogenic cancer chemotherapy , including cisplatin greater equal 50 mg/m2 . initial repeat courses moderately emetogenic cancer chemotherapy . radiotherapy patients receiving either total body irradiation , single high-dose fraction abdomen , daily fractions abdomen ondansetron tablets also indicated prevention postoperative nausea and/or vomiting .",
        "doid_entities": [
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "full prescribing information recommended adults pediatrics ( 2 ) patients severe hepatic impairment : exceed total daily dose 8 mg ( 2.2 , 8.6 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "ondansetron tablets ondansetron tablets ondansetron tablets usp , 4 mg ( ondansetron hydrochloride usp , equivalent 4 mg ondansetron ) white , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 153 \u201d side supplied bottles 30 , 100 , 500 , unit-dose packages 100 ( 10 x 10 ) unit-dose packages 3 ( 1 x 3 ) . bottles 30 ndc 55111-153-30 bottles 100 ndc 55111-153-01 bottles 500 ndc 55111-153-05 unit dose packages 100 ( 10 x 10 ) ndc 55111-153-78 unit dose packages 3 ( 1 x 3 ) ndc 55111-153-13 ondansetron tablets usp , 8 mg ( ondansetron hydrochloride usp , equivalent 8 mg ondansetron ) yellow , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 154 \u201d side supplied bottles 30 , 100 , 500 , unit-dose packages 100 ( 10 x 10 ) unit-dose packages 3 ( 1 x 3 ) . bottles 30 ndc 55111-154-30 bottles 100 ndc 55111-154-01 bottles 500 ndc 55111-154-05 unit dose packages 100 ( 10 x 10 ) ndc 55111-154-78 unit dose packages 3 ( 1 x 3 ) ndc 55111-154-13 ondansetron tablets usp , 16 mg ( ondansetron hydrochloride usp , equivalent 16 mg ondansetron ) white , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 155 \u201d side supplied bottles 30 , 500 unit-dose packages 100 ( 10 x 10 ) . bottles 30 ndc 55111-155-30 bottles 500 ndc 55111-155-05 unit-dose packages 100 ( 10x10 ) ndc 55111-155-78 ondansetron tablets usp , 24 mg ( ondansetron hydrochloride usp , equivalent 24 mg ondansetron ) pink , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 156 \u201d side supplied bottles 30 , 500 , unit-dose packages 100 ( 10 x 10 ) unit-dose packages 1 ( 1 x 1 ) . bottles 30 ndc 55111-156-30 bottles 500 ndc 55111-156-05 unit dose packages 100 ( 10 x 10 ) ndc 55111-156-78 unit dose packages 1 ( 1 x 1 ) ndc 55111-156-11 store 20\u00b0-25\u00b0c ( 68\u00b0-77\u00b0f ) ( usp controlled room temperature ) . dispense tight container defined usp . store blisters cartons .",
    "adverseReactions": "ondansetron contraindicated patients : known hypersensitivity ( e.g . , anaphylaxis ) ondansetron components formulation [ ( 6.2 ) ] receiving concomitant apomorphine due risk profound hypotension loss consciousness",
    "indications_original": "Ondansetron\u00a0\u00a0tablets are indicated for the prevention of nausea and vomiting associated with: \n                  \n                     \n                        highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 .\n                        \n                     \n                     \n                         initial and repeat courses of moderately emetogenic cancer chemotherapy.\n                        \n                     \n                     \n                        radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen\n                     \n                  \n                  Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting.",
    "contraindications_original": "See full prescribing information for the recommended dosage in adults and pediatrics (2) Patients with severe hepatic impairment: do not exceed a total daily dose of 8 mg ( 2.2 , 8.6 )",
    "warningsAndPrecautions_original": "Ondansetron Tablets\n                  \n                  Ondansetron Tablets Ondansetron tablets USP, 4 mg (ondansetron hydrochloride USP, equivalent to 4 mg of ondansetron) are white, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c153\u201d on other side and are supplied in bottles of 30, 100, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 3 (1 x 3). \u00a0 \n                  Bottles of 30 NDC 55111-153-30 \n                  Bottles of 100 NDC 55111-153-01 \n                   Bottles of 500 NDC 55111-153-05 \n                  Unit Dose Packages of 100 (10 x 10) NDC 55111-153-78 \n                   Unit Dose Packages of 3 (1 x 3) NDC 55111-153-13 \u00a0 \n                   Ondansetron tablets USP, 8 mg (ondansetron hydrochloride USP, equivalent to 8 mg of ondansetron) are yellow, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c154\u201d on other side and are supplied in bottles of 30, 100, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 3 (1 x 3). \u00a0 \n                   Bottles of 30 NDC 55111-154-30 \n                   Bottles of 100 NDC 55111-154-01 \n                   Bottles of 500 NDC 55111-154-05 \n                   Unit Dose Packages of 100 (10 x 10) NDC 55111-154-78 \n                  Unit Dose Packages of 3 (1 x 3) NDC 55111-154-13 \u00a0 \n                   Ondansetron tablets USP, 16 mg (ondansetron hydrochloride USP, equivalent to 16 mg of ondansetron) are white, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c155\u201d on other side and are supplied in bottles of 30, 500 and unit-dose packages of 100 (10 x 10). \u00a0 \n                   Bottles of 30 NDC 55111-155-30 \n                   Bottles of 500 NDC 55111-155-05 \n                  Unit-dose packages of 100 (10x10) NDC 55111-155-78 \u00a0 \n                   Ondansetron tablets USP, 24 mg (ondansetron hydrochloride USP, equivalent to 24 mg of ondansetron) are pink, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c156\u201d on other side and are supplied in bottles of 30, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 1 (1 x 1). \u00a0 \n                  Bottles of 30 NDC 55111-156-30 \n                  Bottles of 500 NDC 55111-156-05 \n                  Unit Dose Packages of 100 (10 x 10) NDC 55111-156-78 \n                   Unit Dose Packages of 1 (1 x 1) NDC 55111-156-11 \u00a0 \n                   Store at 20\u00b0-25\u00b0C (68\u00b0-77\u00b0F) (See USP Controlled Room Temperature). Dispense in tight container as defined in the USP. Store blisters in cartons.",
    "adverseReactions_original": "Ondansetron is contraindicated in patients: \n                  \n                     known to have hypersensitivity (e.g., anaphylaxis) to ondansetron or any of the components of the formulation [see Adverse Reactions (6.2)]\n                     \n                     receiving concomitant apomorphine due to the risk of profound hypotension and loss of consciousness",
    "drug": [
        {
            "name": "ONDANSETRON",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7773"
        }
    ]
}